Literature DB >> 15716990

Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia.

H M Robinson1, M Martineau, R L Harris, K E Barber, G R Jalali, A V Moorman, J C Strefford, Z J Broadfield, K L Cheung, C J Harrison.   

Abstract

Deletions from the derivative chromosome 9, der(9), of the translocation, t(9;22)(q34;q11), at the site of the ABL/BCR fusion gene, have been demonstrated by fluorescence in situ hybridisation (FISH), in both Philadelphia chromosome (Ph)-positive chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL). In CML they occur in 10-15% of cases and appear to indicate a worse prognosis, whereas in ALL, the situation is unclear. This study presents the findings of dual fusion FISH used to detect such deletions in a series of 27 BCR/ ABL-positive childhood ALL patients. Metaphase FISH was essential for the accurate interpretation of interphase FISH signal patterns. Three cases (11%) had a single fusion signal, resulting from deletions of the der(9). Three other patients with variant translocations and one with an insertion, also had a single fusion, but with no evidence of deletions. Gain of a fusion in approximately one-third of patients indicated a second Ph, which appears to be a diagnostic marker of Ph-positive ALL. This study shows that the incidence of deletions from the der(9) in childhood ALL is at least as high as that reported for CML.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716990     DOI: 10.1038/sj.leu.2403629

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

Review 1.  Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps.

Authors:  Augusto Villanueva; Sara Toffanin; Josep M Llovet
Journal:  Curr Opin Oncol       Date:  2008-07       Impact factor: 3.645

Review 2.  Cytogenetics and molecular genetics of acute lymphoblastic leukemia.

Authors:  Krzysztof Mrózek; David P Harper; Peter D Aplan
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722

3.  Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment.

Authors:  Cristina Díaz-Barriga; Francisca Villanueva-Flores; Katrin Quester; Andrés Zárate-Romero; Ruben Dario Cadena-Nava; Alejandro Huerta-Saquero
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

4.  An unusual case of high hyperdiploid childhood ALL with cryptic BCR/ABL1 rearrangement.

Authors:  Libuse Lizcova; Zuzana Zemanova; Halka Lhotska; Jan Zuna; Lenka Hovorkova; Ester Mejstrikova; Eva Malinova; Jana Rabasova; Ivan Raska; Lucie Sramkova; Jan Stary; Kyra Michalova
Journal:  Mol Cytogenet       Date:  2014-10-24       Impact factor: 2.009

5.  Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database.

Authors:  Yaping Wang; Jie Huang; Liucheng Rong; Peng Wu; Meiyun Kang; Xuejie Zhang; Qin Lu; Yongjun Fang
Journal:  Oncotarget       Date:  2016-12-13

6.  A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.

Authors:  Maristella Maggi; Steven D Mittelman; Jean Hugues Parmentier; Giorgio Colombo; Massimiliano Meli; Jeannette Marie Whitmire; D Scott Merrell; Julian Whitelegge; Claudia Scotti
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.